Health
UK says new study vindicates delaying 2nd virus vaccine shot – Martinsville Bulletin
LONDON (AP) — Britain’s health chief has hailed a new study suggesting that a single dose of the Oxford-AstraZeneca COVID-19 vaccine provides a high level of protection…
But the Oxford research was greeted with excitement by U.K. officials under pressure to justify their decision to delay the second dose.
That reduction in transmission, as well as the fact there is no hospitalizations, the combination of that is very good news. And it categorically supports the strategy weve been taking on having a 12-week gap between the doses,” Hancock told Sky News.
Some countries, including France, have authorized the AstraZeneca vaccine only for use in people under 65, saying…
-
Business10 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General20 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Business14 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Noosa News13 hours agoShow your Anzac Spirit on the ‘Troop Train’